Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026)
Neuroone Medical Technologies (NMTC) posted Change in Receivables of -$764484.0 for Q1 2026, down 154.72% on a QoQ basis from $1.4 million in Q4 2025, and up 62.71% year-over-year from -$469843.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026) Analysis & Trends
Neuroone Medical Technologies' Change in Receivables history runs 7 years deep, the most recent figure standing at -$764484.0 for Q1 2026.
- Quarterly Change in Receivables rose 62.71% year-over-year to -$764484.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 766.47% YoY) and the FY2025 annual result came in at $1.1 million, up 516.05% from the prior year.
- Change in Receivables was -$764484.0 for Q1 2026 at Neuroone Medical Technologies, down from $1.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.2 million in Q4 2024 and bottomed at -$2.1 million in Q1 2025.
- A 5-year average of $117047.2 and a median of $12098.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 892.25% — and 2025, when it tumbled 16849.45%.
- Neuroone Medical Technologies' Change in Receivables stood at $62082.0 in 2022, then jumped by 775.29% to $543399.0 in 2023, then soared by 303.44% to $2.2 million in 2024, then slumped by 36.27% to $1.4 million in 2025, then sank by 154.72% to -$764484.0 in 2026.
- Business Quant data shows NMTC's Change in Receivables at -$764484.0 in Q1 2026, $1.4 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -764,484.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -764,484.00 |
| Mar 31, 2026 | -764,484.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | -318,780.00 |
| Jun 30, 2025 | -318,780.00 |
| Mar 31, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | -233,915.00 |
| Sep 30, 2024 | -233,915.00 |
| Jun 30, 2024 | -145,088.00 |
| Jun 30, 2024 | -145,088.00 |
| Mar 31, 2024 | 12,240.00 |
| Mar 31, 2024 | 12,240.00 |
| Dec 31, 2023 | 543,399.00 |
| Dec 31, 2023 | 543,399.00 |